Enanta Pharmaceuticals, Inc. Announces The Appointment Of George S. Golumbeski, Ph.D. To Board Of Directors  
2/11/2014 10:12:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of George S. Golumbeski, Ph.D., to its Board of Directors. Dr. Golumbeski will also serve as a member of the Compensation Committee and the Nominating and Corporate Governance Committees.

Help employers find you! Check out all the jobs and post your resume.